Olympiad Research LP Takes Position in Teladoc Health, Inc. (NYSE:TDOC)

Olympiad Research LP acquired a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 20,457 shares of the health services provider’s stock, valued at approximately $186,000.

A number of other institutional investors and hedge funds also recently modified their holdings of TDOC. Point72 Asset Management L.P. increased its stake in shares of Teladoc Health by 57.8% during the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock valued at $76,803,000 after acquiring an additional 3,063,172 shares during the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Teladoc Health during the 3rd quarter valued at about $15,801,000. Maple Rock Capital Partners Inc. acquired a new position in shares of Teladoc Health during the 3rd quarter valued at about $11,291,000. Invenomic Capital Management LP increased its stake in shares of Teladoc Health by 155.2% during the 3rd quarter. Invenomic Capital Management LP now owns 1,474,337 shares of the health services provider’s stock valued at $13,534,000 after acquiring an additional 896,552 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in shares of Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after acquiring an additional 424,180 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Teladoc Health stock opened at $11.52 on Monday. The stock has a market cap of $1.98 billion, a P/E ratio of -2.00 and a beta of 1.05. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The stock has a 50 day moving average of $10.55 and a 200-day moving average of $9.47. Teladoc Health, Inc. has a 52 week low of $6.76 and a 52 week high of $15.95.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Bank of America increased their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Royal Bank of Canada increased their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Piper Sandler reissued an “overweight” rating and set a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. The Goldman Sachs Group increased their target price on shares of Teladoc Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, February 18th. Finally, Oppenheimer dropped their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Thirteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $11.81.

Insider Activity

In other news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.